-
The crystal structure of the estrogen receptor DNA-binding domain bound to DNA: how receptors discriminate between their response elements.
Medical Research Council Laboratory of Molecular Biology, Cambridge, England.
The nuclear hormone receptors are a superfamily of ligand-activated DNA-binding transcription factors. We have determined the crystal structure (at 2.4 A) of the fully specific complex between the DNA-binding domain from the estrogen receptor and DNA. The protein binds as a symmetrical dimer to its palindromic binding site consisting of two 6 bp consensus half sites with three intervening base pairs. This structure reveals how the protein recognizes its own half site sequence rather than that of the related glucocorticoid receptor, which differs by only two base pairs. Since all nuclear hormone receptors recognize one or the other of these two consensus half site sequences, this recognition mechanism applies generally to the whole receptor family.
PMID: 8221895 [PubMed - indexed for MEDLINE]
-
Cited by 66 PubMed Central articles
-
Do Estrogen Receptor beta Polymorphisms Play A Role in the Pharmacogenetics of Estrogen Signaling?
Nott SL, Huang Y, Fluharty BR, Sokolov AM, Huang M, Cox C, Muyan M.
Curr Pharmacogenomics Person Med. 2008 Dec 1; 6(4):239-259.
[Curr Pharmacogenomics Person Med. 2008]
-
What are comparative studies telling us about the mechanism of ERbeta action in the ERE-dependent E2 signaling pathway?
Li X, Huang J, Fluharty BR, Huang Y, Nott SL, Muyan M.
J Steroid Biochem Mol Biol. 2008 Apr; 109(3-5):266-72. Epub 2008 Mar 6.
[J Steroid Biochem Mol Biol. 2008]
-
Estrogen signaling multiple pathways to impact gene transcription.
Marino M, Galluzzo P, Ascenzi P.
Curr Genomics. 2006 Nov; 7(8):497-508.
[Curr Genomics. 2006]
- » See all...
Structures reported by this article